Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSIW) Return on Sales (2022 - 2025)

Historic Return on Sales for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to 0.93%.

  • TriSalus Life Sciences' Return on Sales fell 6100.0% to 0.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.98%, marking a year-over-year increase of 10800.0%. This contributed to the annual value of 1.02% for FY2024, which is 21900.0% up from last year.
  • TriSalus Life Sciences' Return on Sales amounted to 0.93% in Q3 2025, which was down 6100.0% from 0.74% recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Return on Sales peaked at 0.27% during Q3 2023, and registered a low of 6.99% during Q4 2022.
  • Moreover, its 4-year median value for Return on Sales was 1.22% (2024), whereas its average is 2.18%.
  • As far as peak fluctuations go, TriSalus Life Sciences' Return on Sales soared by 50100bps in 2024, and later plummeted by -6100bps in 2025.
  • Quarter analysis of 4 years shows TriSalus Life Sciences' Return on Sales stood at 6.99% in 2022, then increased by 11bps to 6.23% in 2023, then skyrocketed by 80bps to 1.22% in 2024, then grew by 24bps to 0.93% in 2025.
  • Its Return on Sales stands at 0.93% for Q3 2025, versus 0.74% for Q2 2025 and 1.13% for Q1 2025.